Previous Article | Next Article ![]()
Journal of Virology, December 2001, p. 11555-11564, Vol. 75, No. 23
Laboratory for Clinical and Molecular
Virology, University of Edinburgh, Summerhall, Edinburgh EH9
1QH,1 and Regional Infectious
Diseases Unit2 and Department of
Neuropathology,3 Western General Hospital,
Edinburgh EH4 2XU, United Kingdom.
Received 2 May 2001/Accepted 20 August 2001
There is increasing evidence that CD8 lymphocytes may represent
targets for infection by human immunodeficiency virus type 1 (HIV-1) in
vivo whose destruction may contribute to the loss of immune function
underlying AIDS. HIV-1 may infect thymic precursor cells destined to
become CD4 and CD8 lymphocytes and contribute to the numerical decline
in both subsets on disease progression. There is also evidence for the
induction of CD4 expression and susceptibility to infection by HIV-1 of
CD8 lymphocytes activated in vitro. To investigate the relationship
between CD8 activation and infection by HIV-1 in vivo, activated
subsets of CD8 lymphocytes in peripheral blood mononuclear cells
(PBMCs) of HIV-seropositive individuals were investigated for CD4
expression and HIV infection. Activated CD8 lymphocytes were identified
by expression of CD69, CD71, and the human leukocyte antigen (HLA)
class II, the
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.23.11555-11564.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Activated Peripheral CD8 Lymphocytes Express CD4 In Vivo and Are
Targets for Infection by Human Immunodeficiency Virus Type 1
-chain of CD8, and the RO isoform of CD45.
CD4+ and CD4
CD8 lymphocytes, CD4
lymphocytes, other T cells, and non-T cells were purified using
paramagnetic beads, and proviral sequences were quantified by PCR using
primers from the long terminal repeat region. Frequencies of activated
CD8 lymphocytes were higher in HIV-infected study subjects than in
seronegative controls, and they frequently coexpressed CD4 (mean
frequencies on CD69+, CD71+, and HLA class
II+ cells of 23, 37, and 8%, respectively, compared with 1 to 2% for nonactivated CD8 lymphocytes). The level of CD4 expression of the double-positive population approached that of mature CD4 lymphocytes. That CD4 expression renders CD8 cell susceptible to
infection was indicated by their high frequency of infection in vivo;
infected CD4+ CD8 lymphocytes accounted for between 3 and
72% of the total proviral load in PBMCs from five of the eight study
subjects investigated, despite these cells representing a small
component of the PBMC population (<3%). Combined, these findings
provide evidence that antigenic stimulation of CD8 lymphocytes in vivo
induces CD4 expression that renders them susceptible to HIV infection
and destruction. The specific targeting of responding CD8 lymphocytes
may provide a functional explanation for the previously observed
impairment of cytotoxic T-lymphocyte (CTL) function disproportionate to
their numerical decline in AIDS and for the deletion of specific clones of CTLs responding to HIV antigens.
*
Corresponding author. Mailing address: Laboratory for
Clinical and Molecular Virology, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, United Kingdom. Phone: 44 131 650 7927. Fax: 44 131 650 7965. E-mail: Peter.Simmonds{at}ed.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|